edited by Jack A. Roth, MD, FACS, Professor and Bud Johnson Clinical Distinguished Chair, Department of Thoracic and Cardiovascular Surgery, Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center of Innovative Cancer Therapies, Chief, Section of Thoracic Molecular Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA, Waun Ki Hong, MD, DMSc (Hon), American Cancer Society Professor, Samsung Distinguished University Chair in Cancer Medicine, Professor and Head, Division of Cancer Medicine, Professor, Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA, Ritsuko Komaki, MD, FACR, FASTRO, Professor, Department of Radiation Oncology, Gloria Lupton Tennison Distinguished Endowed Professor in Lung Cancer Research, the University of Texas MD Anderson Cancer Center, Houston, TX, USA ; associate editors: Anne S. Tsao, MD, Associate Professor, Director, Mesothelioma Program, Director, Thoracic Chemo-Radiation Program, Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA, Joe Y. Chang, MD, MS, PhD, Professor, Clinical Section Chief, Department of Radiation Oncology, Director of Stereotactic Radiotherapy, the University of Texas MD Anderson Cancer Center, Houston, TX, USA, Shanda H. Blackmon, Associate Professor, Weill Cornell Medical College, Chief, Division of Thoracic Surgery, Houston Methodist Hospital, clinical Assistant Professor, the University of Texas MD Anderson Cancer Center, Houston, TX, USA